Abstract
Pediatric brain tumors, especially embryonal and other high-grade tumor types, have the propensity to disseminate along the cerebrospinal fluid (CSF) pathway, while spread outside the central nervous system (CNS) at diagnosis is very rare. The management of pediatric brain tumors has evolved over the last three decades as a result of prospective multicentric clinical trials. Multimodal treatment including surgical resection, radiotherapy, and chemotherapy has led to improved outcomes in many entities. However, treatment-related toxicity often has a major impact on long-term quality of survival. In order to reduce sequelae, the concept of stratification into risk groups according to clinical variables (e.g., age, presence of metastases detected by imaging or cytological evaluation of CSF, and postoperative residual tumor status) has been developed in the last decades, adjusting the intensity of therapy to the risk of relapse. While the principal treatment strategies have not significantly changed over the past few years, enormous progress has been made in understanding of tumor biology, which has led and most likely will continue to lead to further refinements of risk stratification and to the development of novel therapy approaches using targeted drugs in a personalized way [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Northcott PA, Korshunov A, Pfister SM, Taylor MD. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol. 2012;8:340–51.
Chang CH, Housepian EM, Herbert Jr C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93:1351–9.
Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:4202–8.
Lannering B, Rutkowski S, Doz F, et al. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:3187–93.
Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG. Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape. J Clin Oncol. 2015;33:2986–98.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Warmuth-Metz, M. (2017). The Impact of Staging Examinations in Children and Adolescents with Brain Tumor. In: Imaging and Diagnosis in Pediatric Brain Tumor Studies. Springer, Cham. https://doi.org/10.1007/978-3-319-42503-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-42503-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42501-6
Online ISBN: 978-3-319-42503-0
eBook Packages: MedicineMedicine (R0)